Axcelis Technologies

Emerging58% confidenceProfile verified Jul 15, 2026

Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.

Chokepoint Score

1 other entity structurally depend on this one

Steady

Momentum

insider filing activity unchanged since last check

Headquarters

Beverly, Massachusetts, USA

Website

www.axcelis.com

Employees

1,465 (as of Dec 31, 2025, 10-K)

Founded

1978

Listing

ACLS · NASDAQ

Market Cap

$3.69B

Revenue (TTM)

$845.44M

Price

USD120.03 (-16.19%)

Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.

Overview

A US-based maker of ion implantation equipment, a specialized process step in semiconductor manufacturing used to precisely modify the electrical properties of silicon wafers. Axcelis Technologies reported full-year 2025 revenue of $839.0 million (98.2% from its ion implantation business) with operating profit of $119.3 million (down from $210.8 million in 2024); power-device-focused ion implantation represented 55% of the value of 2025 system shipments, with Wall Street projecting growth resuming to an estimated $921 million in 2027.

Strategic Connections

Taiwan Semiconductor Manufacturing Company: Axcelis supplies ion implantation equipment used in advanced chip manufacturing processes.
Applied Materials: Axcelis competes with Applied Materials' ion implantation product line, though Axcelis specializes as a pure-play implant equipment maker.

Strategic Risks

Smaller, niche equipment category with concentrated demand

Future Outlook

Steady demand tied to overall wafer fab equipment cycles

Sources

3 sources, 84% average source confidence — full citations in the Full Analyst Report.

Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.

Viewing the Executive Summary — switch to the Full Analyst Report.